Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType (TM) Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians ...

On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage ...

This study explored patients' and healthcare professionals' views and knowledge of pharmacogenetic testing and associated future service development. Patients and healthcare professionals discussed ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind, a leader in medication management and personalized medicine through pharmacogenetics (PGx), is proud to announce the release of its innovative Patient ...

Nationwide analysis of Medicare expenditure and utilization of EGFR inhibitors from 2018-2022. Genetic variants and clinical factors affecting the response to 5-fluorouracil–based treatment in Chilean ...

EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a ...

Genedrive (GB:GDR) has released an update. Genedrive PLC, a leader in pharmacogenetic testing, continues to innovate with its Genedrive® MT-RNR1 ID Kit and CYP2C19 ID Kit, enhancing personalized ...

The UK Center of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on the use ...

Genetic testing before chemotherapy may help improve safety and guide treatment for patients with gastrointestinal cancers. Among patients with gastrointestinal cancers, genetic testing before ...

23andMe announced this morning that it has received a 510(k) clearance from the FDA that allows its direct-to-consumer personal pharmacogenetics report to guide use of two treatments without the need ...